PT806202E - Composicao farmaceutica a base de matrizes lipofilas estabilizadas para a libertacao controlada de principios activos - Google Patents
Composicao farmaceutica a base de matrizes lipofilas estabilizadas para a libertacao controlada de principios activosInfo
- Publication number
- PT806202E PT806202E PT97400990T PT97400990T PT806202E PT 806202 E PT806202 E PT 806202E PT 97400990 T PT97400990 T PT 97400990T PT 97400990 T PT97400990 T PT 97400990T PT 806202 E PT806202 E PT 806202E
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceutical composition
- lipofilas
- matrixes
- stabilized
- composition based
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9605606A FR2748209B1 (fr) | 1996-05-06 | 1996-05-06 | Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs |
Publications (1)
Publication Number | Publication Date |
---|---|
PT806202E true PT806202E (pt) | 2002-06-28 |
Family
ID=9491845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT97400990T PT806202E (pt) | 1996-05-06 | 1997-05-02 | Composicao farmaceutica a base de matrizes lipofilas estabilizadas para a libertacao controlada de principios activos |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0806202B1 (pt) |
JP (1) | JP3983339B2 (pt) |
CN (1) | CN1171270A (pt) |
AT (1) | ATE212543T1 (pt) |
AU (1) | AU720146B2 (pt) |
CA (1) | CA2204475C (pt) |
DE (1) | DE69710121T2 (pt) |
DK (1) | DK0806202T3 (pt) |
ES (1) | ES2170922T3 (pt) |
FR (1) | FR2748209B1 (pt) |
HU (1) | HU222045B1 (pt) |
NO (1) | NO318227B1 (pt) |
NZ (1) | NZ314740A (pt) |
PL (1) | PL190562B1 (pt) |
PT (1) | PT806202E (pt) |
ZA (1) | ZA973836B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1011363A3 (fr) * | 1997-09-11 | 1999-08-03 | Smb Technology | Capsules semi-solides autoemulsionnables matricielles a action prolongee. |
FR2782006B1 (fr) * | 1998-08-07 | 2002-04-19 | Gattefosse Ets Sa | Composition a liberation prolongee apte a former une micro-emulsion |
DE10161078A1 (de) * | 2001-12-12 | 2003-08-28 | Achim Goepferich | Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen |
US7635675B2 (en) | 2003-08-13 | 2009-12-22 | Biocon Limited | Micro-particle fatty acid salt solid dosage formulations for therapeutic agents |
GB0324574D0 (en) * | 2003-10-21 | 2003-11-26 | Glaxo Group Ltd | Novel compositions |
EP1951208A2 (en) * | 2005-10-26 | 2008-08-06 | Banner Pharmacaps Inc. | Lipophilic vehicle-based dual controlled release matrix system as capsule fill |
US8333989B2 (en) | 2005-10-26 | 2012-12-18 | Banner Pharmacaps, Inc. | Hydrophilic vehicle-based dual controlled release matrix system |
US8198268B2 (en) | 2008-10-31 | 2012-06-12 | Janssen Biotech, Inc. | Tianeptine sulfate salt forms and methods of making and using the same |
JP2013119540A (ja) * | 2011-12-08 | 2013-06-17 | Nipro Corp | 固形医薬組成物およびその製造法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4797286A (en) * | 1985-11-12 | 1989-01-10 | Eli Lilly And Company | Orally administerable sustained release pharmaceutical formulations |
DE4413350A1 (de) * | 1994-04-18 | 1995-10-19 | Basf Ag | Retard-Matrixpellets und Verfahren zu ihrer Herstellung |
US5545628A (en) * | 1995-01-10 | 1996-08-13 | Galephar P.R. Inc. | Pharmaceutical composition containing fenofibrate |
-
1996
- 1996-05-06 FR FR9605606A patent/FR2748209B1/fr not_active Expired - Fee Related
-
1997
- 1997-05-02 PT PT97400990T patent/PT806202E/pt unknown
- 1997-05-02 DK DK97400990T patent/DK0806202T3/da active
- 1997-05-02 ES ES97400990T patent/ES2170922T3/es not_active Expired - Lifetime
- 1997-05-02 AT AT97400990T patent/ATE212543T1/de active
- 1997-05-02 EP EP97400990A patent/EP0806202B1/fr not_active Expired - Lifetime
- 1997-05-02 DE DE69710121T patent/DE69710121T2/de not_active Expired - Lifetime
- 1997-05-05 CN CN97109780A patent/CN1171270A/zh active Pending
- 1997-05-05 HU HU9700842A patent/HU222045B1/hu not_active IP Right Cessation
- 1997-05-05 CA CA002204475A patent/CA2204475C/fr not_active Expired - Fee Related
- 1997-05-05 AU AU19991/97A patent/AU720146B2/en not_active Ceased
- 1997-05-05 NO NO19972068A patent/NO318227B1/no not_active IP Right Cessation
- 1997-05-05 PL PL97319808A patent/PL190562B1/pl not_active IP Right Cessation
- 1997-05-05 ZA ZA9703836A patent/ZA973836B/xx unknown
- 1997-05-05 NZ NZ314740A patent/NZ314740A/en not_active IP Right Cessation
- 1997-05-06 JP JP11554897A patent/JP3983339B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NZ314740A (en) | 1998-11-25 |
DE69710121T2 (de) | 2002-11-28 |
AU1999197A (en) | 1997-11-13 |
NO972068D0 (no) | 1997-05-05 |
PL190562B1 (pl) | 2005-12-30 |
HUP9700842A1 (hu) | 1998-08-28 |
EP0806202B1 (fr) | 2002-01-30 |
DK0806202T3 (da) | 2002-05-06 |
ZA973836B (en) | 1997-12-02 |
CN1171270A (zh) | 1998-01-28 |
DE69710121D1 (de) | 2002-03-14 |
CA2204475A1 (fr) | 1997-11-06 |
HU9700842D0 (en) | 1997-06-30 |
NO972068L (no) | 1997-11-07 |
FR2748209B1 (fr) | 1998-06-05 |
NO318227B1 (no) | 2005-02-21 |
JP3983339B2 (ja) | 2007-09-26 |
HU222045B1 (hu) | 2003-04-28 |
FR2748209A1 (fr) | 1997-11-07 |
PL319808A1 (en) | 1997-11-10 |
JPH1045629A (ja) | 1998-02-17 |
ES2170922T3 (es) | 2002-08-16 |
EP0806202A1 (fr) | 1997-11-12 |
AU720146B2 (en) | 2000-05-25 |
CA2204475C (fr) | 2002-12-03 |
ATE212543T1 (de) | 2002-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2683146B1 (fr) | Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse. | |
ATE383165T1 (de) | Pharmazeutische zusammensetzung mit verzögerter freisetzung, die wasserunlösliche komplexverbindungen enthalten | |
PT643963E (pt) | Dispositivo biodegradavel para administracao de substancias activas | |
BR9607752B1 (pt) | formulação farmacêutica de microcápsula de liberação controlada. | |
TWI235068B (en) | Sustained-release pharmaceutical composition | |
ZA9811799B (en) | Solid galenic form of the controlled release tablet type for the instant and then prolonged release of one or more active substances | |
DE69833464D1 (de) | Pharmazeutische Zusammensetzung, enthaltend 2,3-Diaryl-PyrazoloÄ1,5-bÜPyridazin Derivate | |
DE3583072D1 (de) | Tablette mit verzoegerter freisetzung. | |
MX9204268A (es) | Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma. | |
ES2099273T3 (es) | Comprimidos de verapamil de liberacion controlada. | |
DK0695177T3 (da) | Plaster indeholdende aktivt stof | |
DE59804823D1 (de) | Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung | |
FI970530A (fi) | Koostumus aktiivisen aineen selektiiviseksi vapauttamiseksi | |
PT806202E (pt) | Composicao farmaceutica a base de matrizes lipofilas estabilizadas para a libertacao controlada de principios activos | |
PT947196E (pt) | Preparação de derivado de prostaglandina i de libertação prolongada | |
NZ314662A (en) | Matrix tablet for the prolonged release of the sodium salt of tianeptine | |
HUT75029A (en) | Systems for controlled release of pilocarpine, and semipermeable capsule containing the active ingredient | |
NO922619D0 (no) | Blanding for kosmetisk stoff, spesielt for deodorantstift | |
MA24331A1 (fr) | Composition antimycosique a forte liberation de substance active | |
ES1004915Y (es) | Dispositivo para vaporizar sustancias termicamente vaporizables. | |
HUT54691A (en) | Anti-parasitical, insecticide, acaricide and nematocide preparatives containing 13-alkyl-23-imino- and 13-halogenic-23-imino-11-f28249 derivatives and process for producing the active substances | |
ATE269061T1 (de) | Calciumhaltige brausetablette mit einem antihistaminikum als wirkstoff | |
DE69416034D1 (de) | Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen | |
KR970000225A (ko) | 시네프린을 유효성분으로 함유하는 우울증 치료제 | |
EP0305194A3 (en) | Veterinary composition |